Exomind
TUSCAN SUN FONTANA MEDSPA
Experience the fountain of youth
Currently available in our West Virginia & Pennsylvania locations
Strengthen Your Mind with EXOMIND™: The Future of Mental Wellness
Overall well-being encompasses more than physical appearance and fitness. Addressing the mind is an essential part of achieving balance and confidence. The breakthrough EXOMIND therapy is designed to treat symptoms of depression, helping patients regain control and improve their quality of life.
Exomind may be the right fit if you struggle with:
- Symptoms of depression or diagnosed MDD
- Persistent anxiety or emotional dysregulation
- Performance-limiting brain fog, low mental clarity, or slowed cognitive function
- Binge eating, uncontrolled food cravings, or impulsive behaviors
- Post-concussion cognitive or mood changes
- Burnout, mental fatigue, or stress-related focus issues
A WORKOUT FOR YOUR MIND!
EXOMIND is designed to treat symptoms of depression, anxiety, low mental clarity, uncontrolled food cravings, impulsive behaviors, mental fatigue and more. Consult with your healthcare provider to determine if EXOMIND is the right option for your mental wellness journey.
Most patients find the therapy comfortable. Sessions are quick, lasting under 30 minutes, and allow you to walk in and walk out with ease.
EXOMIND seamlessly integrates into your daily routine with minimal disruption.
Please discuss risks and contraindications with your healthcare practitioner before beginning treatment.
Comfortable Sessions
Under 30 Minutes
Noninvasive
Drug Free
Walk-In & Walk-Out Procedure
No down-time
Unlock Your Mind with EXOMIND
A ground-breaking mental wellness technology that marks a new era in patient care.
* Important Information:
Patient results and experience may vary. BTL devices should only be used under the continued supervision of a physician or licensed practitioner. Refer to the owner’s manual for the full list of contraindications, side effects, and precautions. †EXOMIND is intended to be used for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. BTL®, EMSCULPT NEO®, NEO™, EMSCULPT®, EMSELLA®, EXILIS®, EMTONE®, HIFEM®, HIFES®, EMFEMME 360®, Core to floor®, EXION®, EMFACE®, ExoTMS™ and EXOMIND™ are trademarks and/or registered trademarks in the United States of America, the European Union, and other countries. The products, the methods of manufacture or their use may be protected by one or more U.S. or foreign patents or pending applications, see www.btlnet.com/patents. Trademarks EMSCULPT, EMSCULPT NEO, EMSELLA, EMTONE, EMFEMME 360, EMFACE and EMBODY are associated with the EM® family of products and services. © 2025 BTL INDUSTRIES, Inc.